Skip to main content

Table 2 List of pre-clinical direct MYC inhibitors

From: MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies

Mechanism

Type

Compound

References

Inhibitor of MYC/Max dimerization

Small Molecule

IIA6B17

[672]

10058-F4

[673]

10074-G5

[674]

JY-3-094

[675]

3jc48–3

[676]

MYCro1, MYCro2, MYCro3

[677]

MYCMI-6

[676]

KJ-Pyr-9

[678]

EN4

[679]

MYCi361

[680]

MYCi975

[681]

KI-MS2-008

[682]

(Poly)peptide

OmoMYC

[683]

FPPa-OmoMYC

[684]

Max bHLHZ (OmoMYC)

[685]

Mxd1

[686]

Monoclonal antibody

[687]

H1 peptide

[688]

Inhibitor of E-box binding

Small Molecule

JKY-2-169

[689]

(Poly)peptide

OmoMYC

[683]

Max bHLHZ

[685]

Mxd1

[686]

ME47

[690]